Covered recipient · General Payments record
STACIE M MCKNIGHT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,894.92
- Reported across 226 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $765.56 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.60 | 11 |
| Amgen Inc. | $57.60 | 3 |
| PFIZER INC. | $56.31 | 3 |
| UCB, Inc. | $48.26 | 1 |
| Acerta Pharma LLC | $44.95 | 3 |
| Edwards Lifesciences Corporation | $43.55 | 1 |
| EISAI INC. | $42.10 | 2 |
| Novo Nordisk AS | $40.43 | 2 |
| GlaxoSmithKline, LLC. | $39.94 | 2 |
| Xeris Pharmaceuticals, Inc. | $37.73 | 2 |
| ABIOMED | $33.51 | 1 |
| Phathom Pharmaceuticals, Inc. | $28.15 | 1 |
| Astellas Pharma US Inc | $20.61 | 1 |
| Lilly USA, LLC | $14.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.50 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006559 | CMS |
| ABBVIE INC. | $33.99 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006561 | CMS |
| ABBVIE INC. | $22.90 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006563 | CMS |
| ABBVIE INC. | $17.96 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006565 | CMS |
| ABBVIE INC. | $27.99 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006567 | CMS |
| ABBVIE INC. | $19.96 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006569 | CMS |
| ABBVIE INC. | $18.01 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006571 | CMS |
| ABBVIE INC. | $26.82 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006573 | CMS |
| ABBVIE INC. | $15.41 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006575 | CMS |
| ABBVIE INC. | $32.90 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006577 | CMS |
| ABBVIE INC. | $32.16 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105006579 | CMS |
| ABIOMED | $33.51 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142274089 | CMS |
| Amgen Inc. | $21.44 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626196 | CMS |
| Amgen Inc. | $15.91 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920547 | CMS |
| Amgen Inc. | $20.25 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626198 | CMS |
| Astellas Pharma US Inc | $20.61 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139440910 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.23 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105820619 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.68 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383327 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.04 | 11/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104587352 | CMS |
| Edwards Lifesciences Corporation | $43.55 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138892325 | CMS |
| Eisai Inc. | $14.68 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110782294 | CMS |
| Eisai Inc. | $27.42 | 09/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110782292 | CMS |
| GlaxoSmithKline, LLC. | $19.11 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116268338 | CMS |
| GlaxoSmithKline, LLC. | $20.83 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116377268 | CMS |
| Lilly USA, LLC | $14.82 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410699 | CMS |
| Novo Nordisk Inc | $17.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097007639 | CMS |
| Novo Nordisk Inc | $22.44 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568150 | CMS |
| PFIZER INC. | $14.59 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132051186 | CMS |
| PFIZER INC. | $19.87 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132050736 | CMS |
| PFIZER INC. | $21.85 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132068003 | CMS |
| Phathom Pharmaceuticals, Inc. | $28.15 | 09/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151095289 | CMS |
| UCB, Inc. | $48.26 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143052945 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.02 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144614178 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.71 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144614180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.